Keener Financial Planning’s AbbVie ABBV Stock Holding History

Keener Financial Planning’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-400	Closed	-$92K	–	60
2025 Q3	$92K	Hold	400	–	–	0.04%	76
2025 Q2	$74K	Hold	400	–	–	0.04%	87
2025 Q1	$83K	Hold	400	–	–	0.05%	65
2024 Q4	$71K	Hold	400	–	–	0.04%	79
2024 Q3	$78K	Hold	400	–	–	0.05%	68
2024 Q2	$68K	Hold	400	–	–	0.04%	79
2024 Q1	$73K	Hold	400	–	–	0.05%	76
2023 Q4	$62K	Buy	+400	New	+$58.3K	0.05%	83

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Keener Financial Planning's ABBV Position: Q4 2025 in Review

Keener Financial Planning sold out of AbbVie (ABBV) in Q4 2025, closing a stake of 400 shares — an estimated $92K sold.

Keener Financial Planning first reported a position in ABBV in Q4 2023 and held it in 8 quarters. The position peaked at $92K in Q3 2025. 4,156 funds tracked by Wall St. Rank hold ABBV as of Q4 2025.

Keener Financial Planning reported no remaining AbbVie position as of Q4 2025 after selling out during the quarter.
Keener Financial Planning sold 400 AbbVie shares in Q4 2025, an estimated $92K.
Keener Financial Planning first reported a position in AbbVie in Q4 2023 and held it in 8 quarters.
Keener Financial Planning's AbbVie position peaked at $92K in Q3 2025.
4,156 funds tracked by Wall St. Rank held AbbVie as of Q4 2025.

Based on Keener Financial Planning's 13F filing for Q4 2025, filed 23 Jan 2026.